Maura Cosetti, MD, an LSU Health Shreveport otolaryngologist and head & neck surgery assistant professor, is currently offering a revolutionary hybrid hearing technology to those with hearing difficulties too pronounced for traditional hearing devices but not pronounced enough for a cochlear implant.
Recently approved by the U.S. Food and Drug Administration (FDA), the Cochlear Nucleus Hybrid Implant features traditional cochlear implant technology and a built-in hearing device to boost the wearer’s existing hearing range. By doing so, the roughly 738,000 Americans with severe-to-profound hearing loss will now have greater access to a more comfortable listening experience.
This hybrid approach is just one of the recent advancements made in implant technology, including an invisible implant and positive steps toward using gene therapy and biotechnology to bolster an implant’s strength.
Last updated: July 29, 2014